Alveolar hypoxia is the most prominent feature of high altitude environment with well-known
consequences for the cardio-pulmonary system, including development of pulmonary …

High-altitude pulmonary hypertension (HAPH) affects individuals residing at altitudes of
2,500 meters and higher. Numerous pathogenic variables play a role in disease inception …

Almost one mountain trekker or climber out of two develops several symptoms of high
altitude illness after a rapid ascent (> 300 m/day) to an altitude above 4000 m. Individual …

With rising altitude the partial pressure of oxygen falls. This phenomenon leads to hypobaric
hypoxia at high altitude. Since more than 140 million people permanently live at heights …

Pulmonary hypertension is a hallmark of high-altitude pulmonary oedema (HAPE) and of
congestive right heart failure in subacute mountain sickness (SMS) and chronic mountain …

We distinguish two forms of high altitude illness, a cerebral form called acute mountain
sickness and a pulmonary form called high-altitude pulmonary edema (HAPE). Individual …

Globally, it is estimated that> 140 million people live at a high altitude (HA), defined as>
2,500 m (8,200 ft), and that countless others sojourn to the mountains for work, travel, and …

High altitude pulmonary edema (HAPE) is a non-cardiogenic pulmonary edema that can
occur in healthy individuals who ascend rapidly to altitudes above 3000–4000m. Excessive …

Abstract Dehnert, Christoph, Derliz Mereles, Sebastian Greiner, Dagmar Albers, Fabian
Scheurlen, Stefanie Zügel, Thomas Böhm, Peter Vock, Marco Maggiorini, Ekkehard Grünig …

High-altitude pulmonary edema (HAPE) is a life-threatening noncardiogenic form of
pulmonary edema (PE) that afflicts susceptible persons after rapid ascent to high altitude …